Apontis Pharma AG
XETRA:APPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apontis Pharma AG
XETRA:APPH
|
DE |
|
Coventry Group Ltd
ASX:CYG
|
AU |
|
C
|
Cancom SE
XETRA:COK
|
DE |
|
G
|
Golden Sun Education Group Ltd
NASDAQ:GSUN
|
CN |
|
Sheng Siong Group Ltd
SGX:OV8
|
SG |
|
Jins Holdings Inc
TSE:3046
|
JP |
|
Newpark Resources Inc
NYSE:NR
|
US |
|
N
|
Novolipetsk Steel PAO
LSE:NLMK
|
RU |
|
COSCO SHIPPING Development Co Ltd
SSE:601866
|
CN |
Apontis Pharma AG
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 176 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
